Plasma Noradrenaline and Neuropeptide-Y may not be of Primary Importance in the Pathophysiology of Cardiac Involvement in Systemic Sclerosis

References

• Medsger TA Jr. Systemic sclerosis (Scleroderma), eosinophilic fascitis, and calcinosis. In: McCarthy DJ, ed. Arthritis and allied conditions. A textbook of Rheumatology. Philadelphia: Lea & Febiger, 1985:994–1036.
   Google Scholar
• Smith JW, Clements PJ, Levisman J, Furst D, Ross M. Echocardiographic features of progressive systemic sclerosis (PSS). Correlation with haemodynamic and postmortem studies. Am J Med 1979;66:28–33.
   Google Scholar
• Montanes P, Lawless C, Black C, Oakely CM, Hughes G. The heart in scleroderma: Non-invasive assessment. Clin Cardiol 1982;5:383–7.
   Google Scholar
• Medsger TA Jr, Masi AT, Rodnan GP, et al. Survival with systemic sclerosis (scleroderma). A life table analysis of clinical and demographic factors in 309 patients. Ann Intern Med 1971;75:369–76.
   Google Scholar
• Deswal A, Follansbee WP. Cardiac involvement in sclero-derma. Rheum Dis Clin North Am 1996;22:841–60.
   PubMed Web of Science ®Google Scholar
• Kazzam E, Caidahl K, Gustafsson R, Gustafsson T, Hällgren R, Landelius J, et al. Two-dimensional echocardiographic dimensions in systemic sclerosis and a matched reference population. Am J Noninvas Cardiol 1991;5:343–52.
   Google Scholar
• Kazzam E, Caidahl K, Gustafsson R, Hällgren R, Landelius J, Waldenström A. Non invasive assessment of left ventricular systolic function in systemic sclerosis. Eur Heart J 1991;12:151–6.
   Google Scholar
• Kazzam E, Waldenström A, Landelius J, Hällgren R, Arvidsson A, Caidahl K. Non-invasive assessment of left ventricular diastolic function in systemic sclerosis. J Int Med 1990;228:183–92.
   PubMed Web of Science ®Google Scholar
• Kazzam E, Caidahl K, Hällgren R, Johansson C, Waldenström A. Mitral regurgitation and diastolic flow profile in systemic sclerosis. Int J Cardiol 1990;29:357–63.
   Google Scholar
• Follansbee WP. The cardiovascular manifestation of systemic sclerosis (scleroderma). Curr Probl Cardiol 1986;5:242–98.
   Google Scholar
• Gottdiener JS, Moutsopoulos HM, Decker JL. Echocardio-graphic identification of cardiac abnormality in scleroderma and related disorders. Am J Med 1979;66:391–8.
   Google Scholar
• Kazzam E. Non-invasive assessment of left ventricular function in patients with systemic sclerosis: with special emphasis on the long term cardiac effects of captopril. Thesis, Medical Faculty. Uppsala University, ISBN 91-5542627–1.
   Google Scholar
• Gustafsson R, Mannting F, Kazzam E, Waldenström A, Hällgren R. Cold-induced reversible myocardial ischaemia in systemic sclerosis. Lancet 1989;2:475–9.
   Google Scholar
• Goldstein DS, McCarty R, Polinsky RJ, Kopin IJ. Relation between plasma norepinephrine and sympathetic neural activity. Hypertension 1983;5:552–9.
   PubMed Web of Science ®Google Scholar
• Cohn JN. Plasma Norepinephrine and mortality. Clin Cardiol 1995;18 Suppl 1:9–12.
   Google Scholar
• Levine TB, Francis GS. R, Goldsmith SR, Simon A, Cohn JN. Activity of the sympathetic nervous system and renin-angiotensin system as assessed by plasma hormone levels and their relationship to hemodynamic abnormalities in heart failure. Am J Cardiol 1982;49:1659–66.
   PubMed Web of Science ®Google Scholar
• Francis GS, Benedict C, Johnston DE, Kirlin PC, Nick J, Liange C-S, et al. Comparison of neuroendocrine activation in patients patients with left ventricular dysfunction with and without congestive heart failure. Circulation 1990;82:1724–9.
   Google Scholar
• Thomas JA, Marks BH. Plasma norepinephrine in congestive heart failure. Am J Cardiol 1978;41:233–7.
   PubMed Web of Science ®Google Scholar
• Clarke G, Kerwin J, Larkin S, Lee Y, Yacoub M, Davies J, et al. Coronary artery infusion of neuropeptide Y in patients with angina pectoris. Lancet 1987;1:1057–9.
   Google Scholar
• Dessein PH, Joffe BI, Metz RM, Millar DL, Lawson M, Stanwix AE. Autonomic dysfunction in systemic sclerosis: sympathetic overactivity and instability. The Am J Med 1992;9:143–50.
   Google Scholar
• Kazzam E, Hedner T, Caidahl K, Waldenström A. Functional Explanation for Increased Atrial Natriuretic Peptide in Systemic Sclerosis. Clin Cardiol 1995;18:647–52.
   Google Scholar
• Kazzam E, Waldenström A, Hedner T, Hedner J and Caidahl K. Endothelin May be Pathogenic in Systemic Sclerosis of the Heart. Int J Cardiol 1997;60:31–9.
   Google Scholar
• Subcommittee for scleroderma criteria of American Rheuma-tism Association diagnostic and therapeutic criteria commit-tee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581–90.
   Google Scholar
• Feng QP, Hedner T, Andersson B, Lundberg JM, Waagstein F. Cardiac neuropeptide Y and noradrenaline balance in patients with congestive heart failure. Br Heart J 1994;71:261–7.
   Google Scholar
• Kaijser L, Pernow J, Berglund B, Lundberg JM. Neuropeptide Y is released togther with noradreanline from the human heart during exercise and hypoxia. Clinical Physiol 1990;10:179–88.
   PubMedGoogle Scholar
• Erlinge D, Ekman R, Thulin T, Edvinsson L. Neuropeptide Y-1 like immunoreactivity and hypertension. J Hypertension 1992;10:1221–5.
   PubMed Web of Science ®Google Scholar
• Erlinge D. The sympathetic co-transmitters neuropeptide Y and ATP in the regulation of the vascular smooth muscle cell. Thesis, Medical Faculty, University of Lund, 1994.
   Google Scholar
• Akesson A, Ekman R. Gastrointestinal regulatory peptides in systemic sclerosis. Arthritis Rheum 1993;36:698–703.
   Google Scholar
• LeRoy EC. Increased collagen synthesis by scleroderma skin fibroblasts in vitro. A possible defect in the regulation of activation of the scleroderma fibroblast. J Clin Invest 1974;58:880–9.
   Google Scholar
• Elsner D. Changes in neurohumoral systems during the development of congestive heart failure: impact on cardio-vascular and renal function. Eur Heart J 1995;16 Suppl N:52–8.
   Google Scholar
• Federmann M and Hess OM. Differentiation between systolic and diastolic dysfunction. Eur Heart J 1994;15 Suppl D:2–6.
   Google Scholar
• Kubo SH, Clark M, Laragh JH, Borer JS, Cody RJ. Identification of normal neurohormonal activity in mild congestive heart failure and stimulating effect of upright posture and diuretics. Am J Cardiol 1987;60:1322–8.
   Google Scholar
• Kazzam E, Caidahl K, Gustafsson R, Hällgren R, Waldenström A. Long term cardiac effects of captopril in systemic sclerosis: Non-invasive evaluation. J Int Med 1991;230:203–12.
   Google Scholar